Global Respiratory Devices Market Set To Grow To$7.1 billion By 2017

Thursday, July 21st, 2011 at 8:06 PM

The global respiratory devices market is set to reach $7.1 billion by 2017
The PAP device market is the largest segment in the global respiratory devices market and accounted for 58% of the market
The US market for respiratory devices was valued at $2.4 billion in 2010

The global respiratory devices market is forecast to grow from $4.5 billion in 2010 to $7.1 billion by 2017, according to a new report available on companiesandmarkets.com.

Respiratory Devices – Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
http://www.companiesandmarkets.com/Market-Report/respiratory-devices-global-pipeline-analysis,-competitive-landscape-and-market-forecasts-to-2017-631599.asp?prk=7c4ed5b510c1ffe12b50d9829eddaba2

The PAP device market is the largest segment in the global respiratory devices market and accounted for almost 58% of the total revenue generated in 2010. The PAP device segment will continue to witness high growth and remain as the largest segment in future. The global market for PAP is forecast to grow from $2.6 billion in 2010 to about $4.4 billion by 2017, with a CAGR of 8%. Availability of reimbursement for the PAP devices is expected to drive the market growth.

The US respiratory devices market was valued at $2.4 billion in 2010 and is forecast to grow at a CAGR of 8% to reach $4 billion in 2017. The US is the biggest market globally, contributing 53% towards the global respiratory device market in 2010. In the US, the demand for respiratory products is mainly driven by increasing incidence of the respiratory diseased population. According to the National Health Statistics Report, in the US in 2009, 24.8 million people in the US were affected by asthma. In 2008, more than 12 million people over the age of 18 were estimated to have COPD in the US. Moreover, the market is expected to be driven by the increasing home healthcare devices for the respiratory diseases treatment.

In 2010, ResMed was the leader in the global respiratory devices market with a share of 14%. The company has a major presence in PAP devices and humidifiers which are used for treating Obstructive Sleep Apnea (OSA). The respiratory devices market is highly fragmented with numerous local and international players.

Report Details: http://www.companiesandmarkets.com/Market-Report/respiratory-devices-global-pipeline-analysis,-competitive-landscape-and-market-forecasts-to-2017-631599.asp?prk=7c4ed5b510c1ffe12b50d9829eddaba2